These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36194927)

  • 1. Myhre syndrome is caused by dominant-negative dysregulation of SMAD4 and other co-factors.
    Alankarage D; Enriquez A; Steiner RD; Raggio C; Higgins M; Milnes D; Humphreys DT; Duncan EL; Sparrow DB; Giampietro PF; Chapman G; Dunwoodie SL
    Differentiation; 2022; 128():1-12. PubMed ID: 36194927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first two Chinese Myhre syndrome patients with the recurrent SMAD4 pathogenic variants: Functional consequences and clinical diversity.
    Li H; Cheng B; Hu X; Li C; Su J; Zhang S; Li L; Li M; Yang K; He S; Chen S; Wang H; Liu G; Shen Y
    Clin Chim Acta; 2020 Jan; 500():128-134. PubMed ID: 31654632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function pathogenic variants in SMAD4 are associated with neoplasia in Myhre syndrome.
    Lin AE; Alali A; Starr LJ; Shah N; Beavis A; Pereira EM; Lindsay ME; Klugman S
    Am J Med Genet A; 2020 Feb; 182(2):328-337. PubMed ID: 31837202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome.
    Lin AE; Michot C; Cormier-Daire V; L'Ecuyer TJ; Matherne GP; Barnes BH; Humberson JB; Edmondson AC; Zackai E; O'Connor MJ; Kaplan JD; Ebeid MR; Krier J; Krieg E; Ghoshhajra B; Lindsay ME
    Am J Med Genet A; 2016 Oct; 170(10):2617-31. PubMed ID: 27302097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome.
    Le Goff C; Mahaut C; Abhyankar A; Le Goff W; Serre V; Afenjar A; Destrée A; di Rocco M; Héron D; Jacquemont S; Marlin S; Simon M; Tolmie J; Verloes A; Casanova JL; Munnich A; Cormier-Daire V
    Nat Genet; 2011 Dec; 44(1):85-8. PubMed ID: 22158539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome.
    Kandhaya-Pillai R; Hou D; Zhang J; Yang X; Compoginis G; Mori T; Tchkonia T; Martin GM; Hisama FM; Kirkland JL; Oshima J
    Geroscience; 2021 Jun; 43(3):1481-1496. PubMed ID: 33428109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myhre and LAPS syndromes: clinical and molecular review of 32 patients.
    Michot C; Le Goff C; Mahaut C; Afenjar A; Brooks AS; Campeau PM; Destree A; Di Rocco M; Donnai D; Hennekam R; Heron D; Jacquemont S; Kannu P; Lin AE; Manouvrier-Hanu S; Mansour S; Marlin S; McGowan R; Murphy H; Raas-Rothschild A; Rio M; Simon M; Stolte-Dijkstra I; Stone JR; Sznajer Y; Tolmie J; Touraine R; van den Ende J; Van der Aa N; van Essen T; Verloes A; Munnich A; Cormier-Daire V
    Eur J Hum Genet; 2014 Nov; 22(11):1272-7. PubMed ID: 24424121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SMAD4 mutation causing Myhre syndrome.
    Caputo V; Bocchinfuso G; Castori M; Traversa A; Pizzuti A; Stella L; Grammatico P; Tartaglia M
    Am J Med Genet A; 2014 Jul; 164A(7):1835-40. PubMed ID: 24715504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An additional patient with SMAD4-Juvenile Polyposis-Hereditary hemorrhagic telangiectasia and connective tissue abnormalities: SMAD4 loss-of-function and gain-of-function pathogenic variants result in contrasting phenotypes.
    Gheewalla GM; Luther J; Das S; Kreher JB; Scimone ER; Wong AW; Lindsay ME; Lin AE
    Am J Med Genet A; 2022 Oct; 188(10):3084-3088. PubMed ID: 35869926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe constipation in a patient with Myhre syndrome: a case report.
    Bassett JK; Douzgou S; Kerr B
    Clin Dysmorphol; 2016 Apr; 25(2):54-7. PubMed ID: 26636501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myhre syndrome.
    Le Goff C; Michot C; Cormier-Daire V
    Clin Genet; 2014 Jun; 85(6):503-13. PubMed ID: 24580733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Myhre syndrome mimicking juvenile scleroderma.
    Jensen B; James R; Hong Y; Omoyinmi E; Pilkington C; Sebire NJ; Howell KJ; Brogan PA; Eleftheriou D
    Pediatr Rheumatol Online J; 2020 Sep; 18(1):72. PubMed ID: 32917212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A child with Myhre syndrome presenting with corectopia and tetralogy of Fallot.
    Alagia M; Cappuccio G; Pinelli M; Torella A; Brunetti-Pierri R; Simonelli F; Limongelli G; Oppido G; Nigro V; Brunetti-Pierri N;
    Am J Med Genet A; 2018 Feb; 176(2):426-430. PubMed ID: 29230941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myhre syndrome: A first familial recurrence and broadening of the phenotypic spectrum.
    Meerschaut I; Beyens A; Steyaert W; De Rycke R; Bonte K; De Backer T; Janssens S; Panzer J; Plasschaert F; De Wolf D; Callewaert B
    Am J Med Genet A; 2019 Dec; 179(12):2494-2499. PubMed ID: 31595668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAD4 mutations causing Myhre syndrome are under positive selection in the male germline.
    Wood KA; Tong RS; Motta M; Cordeddu V; Scimone ER; Bush SJ; Maxwell DW; Giannoulatou E; Caputo V; Traversa A; Mancini C; Ferrero GB; Benedicenti F; Grammatico P; Melis D; Steindl K; Brunetti-Pierri N; Trevisson E; Wilkie AO; Lin AE; Cormier-Daire V; Twigg SR; Tartaglia M; Goriely A
    Am J Hum Genet; 2024 Sep; 111(9):1953-1969. PubMed ID: 39116879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome.
    Caputo V; Cianetti L; Niceta M; Carta C; Ciolfi A; Bocchinfuso G; Carrani E; Dentici ML; Biamino E; Belligni E; Garavelli L; Boccone L; Melis D; Andria G; Gelb BD; Stella L; Silengo M; Dallapiccola B; Tartaglia M
    Am J Hum Genet; 2012 Jan; 90(1):161-9. PubMed ID: 22243968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan.
    Piccolo P; Mithbaokar P; Sabatino V; Tolmie J; Melis D; Schiaffino MC; Filocamo M; Andria G; Brunetti-Pierri N
    Eur J Hum Genet; 2014 Aug; 22(8):988-94. PubMed ID: 24398790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and life-threatening complications in Myhre syndrome and review of the literature.
    Garavelli L; Maini I; Baccilieri F; Ivanovski I; Pollazzon M; Rosato S; Iughetti L; Unger S; Superti-Furga A; Tartaglia M
    Eur J Pediatr; 2016 Oct; 175(10):1307-15. PubMed ID: 27562837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A newborn male with Myhre syndrome, hearing loss, and complete syndactyly of fingers 3-4.
    Yang K; Wang X; Wang WQ; Han MY; Hu LM; Kang DY; Yang JY; Liu M; Gao X; Yuan YY; Xu JC
    Mol Genet Genomic Med; 2023 Mar; 11(3):e2103. PubMed ID: 36373990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain-of-function variants in SMAD4 compromise respiratory epithelial function.
    Lindsay ME; Scimone ER; Lawton J; Richa R; Yonker LM; Di YP; Buch K; Ouyang W; Mo X; Lin AE; Mou H
    J Allergy Clin Immunol; 2024 Sep; ():. PubMed ID: 39243984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.